GHK-Cu is the most researched copper peptide in dermatology and wound healing science β with a published literature spanning 50 years from its 1973 isolation to current mechanistic research. This page covers what the research actually shows: the fibroblast activation data, collagen synthesis mechanisms, MMP inhibition, Nrf2 pathway, and how to design GHK-Cu skin biology studies.
Discovery and Background
GHK-Cu was first isolated in 1973 by Loren Pickart, who identified a plasma fraction that stimulated the synthesis of proteins characteristic of younger liver cells in aged tissue. Subsequent characterisation identified the active component as the tripeptide glycyl-histidyl-lysine (GHK) bound to copper(II) ions naturally present in plasma. This discovery initiated 50 years of research into copper peptide biology β now one of the most studied areas of cosmetic and wound healing dermatology.
GHK is naturally present in human blood plasma (~200ng/mL at age 20, declining to ~80ng/mL by age 60), saliva, and urine. The age-related decline in plasma GHK has been proposed as a contributing factor to age-related changes in skin collagen density and wound healing capacity β though the evidence for this hypothesis in humans is correlational rather than causal.
Mechanisms of Action
Gene Expression Research
A particularly striking area of GHK-Cu research is its broad effects on gene expression in aged fibroblasts. Pickart’s group and subsequent researchers have documented that GHK-Cu reverses a large proportion of the gene expression changes that characterise chronologically aged skin fibroblasts β with hundreds of genes shifted towards expression patterns of younger cells. This has been studied using microarray and RNA-seq analysis of GHK-Cu treated vs untreated aged fibroblast cultures. The research suggests GHK-Cu may act as an epigenetic reset signal rather than a simple growth factor β a hypothesis that remains an active area of investigation.
Research Protocol Reference
| Model | GHK-Cu concentration | Duration | Key endpoints |
|---|---|---|---|
| Human fibroblast culture | 0.1β100 nM | 24β96 hours | Collagen I/III/IV mRNA, MMP-1/2/9 expression, proliferation (Ki67), migration (scratch assay) |
| Aged fibroblast model | 1β100 nM | 48β72 hours | Gene expression vs young fibroblast baseline, Nrf2 target genes, antioxidant enzyme activity |
| Excisional wound (rodent) | 0.1β10 mg/kg topical or SC | 7β21 days | Wound closure rate, tensile strength, histology, collagen density, angiogenesis |
| 3D skin equivalent | 1β100 nM in culture medium | 5β14 days | Epidermis thickness, collagen deposition, elastic fibre density, VEGF secretion |
Frequently Asked Questions
What is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It was first isolated by Loren Pickart in 1973 from human plasma as a fraction that stimulated liver cell growth. GHK-Cu consists of the tripeptide Gly-His-Lys bound to a copper(II) ion β the copper being essential for its biological activity. Research has documented effects on fibroblast activation, collagen and elastin synthesis, angiogenesis, wound healing, and antioxidant gene expression.
How does GHK-Cu stimulate collagen synthesis?
GHK-Cu activates fibroblasts to upregulate collagen synthesis through multiple pathways: direct TGF-Ξ² (transforming growth factor-beta) pathway stimulation; upregulation of collagen type I, III, and IV gene expression; and inhibition of MMP (matrix metalloproteinase) activity that would otherwise degrade newly synthesised collagen. The copper ion plays a direct role in the activation of lysyl oxidase, an enzyme required for collagen cross-linking that gives collagen its structural tensile strength. In wound healing models, GHK-Cu accelerates collagen deposition and improves tensile strength of healed tissue.
What is the role of copper in GHK-Cu activity?
Copper is not incidental in GHK-Cu β it is required for biological activity. The copper(II) ion creates a coordination complex with the Gly-His-Lys tripeptide backbone, and this complex is the bioactive form. Copper plays three roles: it stabilises the peptide, enables interaction with specific cell surface receptors, and directly activates copper-dependent enzymes including lysyl oxidase (collagen cross-linking) and superoxide dismutase (Cu/Zn-SOD, antioxidant defence). Copper-free GHK (without the Cu2+) has significantly reduced biological activity.
Does GHK-Cu have anti-ageing effects in research?
Multiple studies have documented GHK-Cu effects relevant to skin ageing research: increased fibroblast proliferation and collagen/elastin synthesis; reduced MMP expression that degrades aged ECM; activation of Nrf2 antioxidant response element genes; reversal of gene expression patterns characteristic of aged skin fibroblasts towards more youthful patterns in cell culture models; and wound healing acceleration. Whether these in vitro effects translate to clinically significant anti-ageing outcomes in vivo is an active research question not fully answered by existing clinical data.
How should GHK-Cu be reconstituted and stored?
Reconstitute GHK-Cu in sterile water or PBS at slightly acidic pH (5β6) β alkaline conditions reduce copper complex stability. Store lyophilized powder at -20Β°C. Reconstituted solution should be used within 2 weeks refrigerated. Protect from oxidation β copper is redox-active and the solution should be prepared fresh or stored in inert containers. Avoid freeze-thaw cycles of reconstituted solution.
GHK-Cu Β· BPC-157 Β· TB-500